ヘム酸素酵素-1 (HO-1) 減少は,卵巣がんにおけるNCOA4媒介フェリチノファギーを強化することによって,シスプラチン抵抗を逆転させるフェロプトーシスを促進する
Huan Wang1, Panpan Zhang1, Qi Cheng1
1Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433, Shanghai, China.
International journal of biological macromolecules
|September 4, 2025
まとめ
ヘム酸素酶-1 (HO-1) の過剰発現は卵巣がんにおけるシスプラチン耐性を引き起こす. HO-1を阻害すると,細胞死経路であるフェロプトーシスが促進され,それによって抵抗が逆転し,新しい治療戦略が提供されます.
科学分野:
- 腫瘍学
- 分子生物学
- 細胞 死 の 仕組み
背景:
- 卵巣がんは 婦人科がんによる死亡の主な原因です
- シスプラチン耐性は治療の有効性を著しく制限する.
- ヘム酸素酵素-1 (HO-1) はがんの進行と薬剤耐性に関与しています.
研究 の 目的:
- 卵巣がんにおけるシスプラチン耐性におけるHO-1の役割を調査する.
- HO-1とフェロプトーシスとフェリチノファギーを結びつけるメカニズムを解明する.
- シスプラチン耐性を克服するための戦略としてHO-1抑制を評価する.
主な方法:
- シスプラチン耐性卵巣がん細胞および組織におけるHO-1発現の分析
- 化学阻害剤とsiRNAを用いてHO-1を抑制する.
- フェロプトーシス,フェリチノファジー,不活性鉄プール (LIP),脂質過酸化,グルタチオン (GSH) レベルの評価
- 異種移植モデルを用いた in vivo 研究
主要な成果:
- HO-1はシスプラチン耐性卵巣がんにおいて有意に過剰発現し,予後不良と相関していた.
- HO-1 枯渇はフェロプトーシスを誘発することによってシスプラチン抵抗を逆転させた.
- HO-1抑制は核受容体共活性化剤4 (NCOA4) 媒介によるフェリチノファギーを強化し,LIPと脂質過酸化を増加させ,GSHを減少させた.
- シスプラチンとHO-1阻害の組み合わせは,体内で腫瘍の成長を抑制しました.
結論:
- HO-1はシスプラチン耐性卵巣がんにおける鉄代謝とフェロプトーシスの重要な調節剤である.
- HO-1の減少は,NCOA4媒介のフェリチノファギーと強化されたフェロプトーシスを通してシスプラチン抵抗を逆転させます.
- シスプラチンとHO-1阻害剤を併用した治療は,卵巣がんの治療に有望である.
関連する概念動画
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Peroxisomes
14.3K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
14.3K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


